Loading...
OTCM
TNPH
Market cap5mUSD
Dec 27, Last price  
0.01USD
Name

Hanyuan Biotech International Inc

Chart & performance

D1W1MN
OTCM:TNPH chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
74.11%
Rev. 5Y
44.63%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
612,2883,520,2607,075,59010,650,75300007,500142,84000
Net income
-5k
L+228.40%
98,701921,6861,520,2203,142,925-22,726-114,153-80,075-31,395-20,449-16,027-1,412-4,637
CFO
-9k
L+173.60%
-1,918,1101,741,1921,461,3772,561,75118,195-87,595-78,719-26,219-14,038-13,024-3,178-8,695

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tian'an Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. It also engages in the research and development of biology goods and health care products. The company's pharmaceutical and nutraceutical products include Compound Ginseng capsule, a Chinese medicine preparation that is used to cure and treat prostate gland proliferation; Nizhuanle Yin granule, a Chinese medicine preparation that treats the decomposition or inflammation of the stomach's mucous membrane; and Tianan soft capsule, which is used to adjust high amounts of fat in the blood stream, improve blood vessel ventilation, and soften blood vessels. Its products also include Tianan Pain Relief Capsule, a Chinese medicine preparation, which is under development to cure pain in joints, headache, pain from muscle injury, cancer, and gynecological disorders, as well as general pain. Tian' An Pharmaceutical sells its products to independent distributors, who sell products to pharmacies and drugstores, and hospitals. The company was founded in 2003 and is based in Xi'an, China.

Key people

Jianjun Weng
Chief Executive Officer, Director · since 2003
Wei Li
Chief Financial and Accounting Officer · since 2008
Andong Jia
Chief Administrative Officer · since 2004
Huachu Tang
Chief Investment Officer · since 2004
Peng Xi
Chief Marketing Officer · since 2004
Mingqi Sun
Chief Quality Officer · since 2007
Hailiang Xue
Chief Production Officer · since 2003
Renhua Wang
Secretary · since 2003
Jinming Gao
Director · since 2008
Ning Jia
Director · since 2003
Deshun Li
Director · since 2004
Zhiguo Ma
Director · since 2005
Ping Ren
Director · since 2006
Yanqing Wang
Director · since 2006
Hongwei Wang
Director · since 2003
IPO date
Jun 25, 2007
Employees
Domiciled in
CN
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT